Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes

NCT: NCT07325461 · COMPLETED

NCT IDNCT07325461
StatusCOMPLETED
Start Date2026-02-18
Completion2026-06-24
SponsorTandem Diabetes Care, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This feasibility study is a prospective, single center, multi-arm study evaluating possible enhancements to the SteadiSet extended wear infusion set.

Frequently Asked Questions

What is Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes?

Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes is a clinical trial registered under NCT07325461. Current status: COMPLETED.

What is the status of NCT07325461?

The current status of NCT07325461 (Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes) is: COMPLETED.

When did Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes start?

Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes started on 2026-02-18.

Related Devices

K251854SteadiSet infusion setTandem Diabetes Care PMA P140015Pump, infusion, insulin, to be used with invasive glucose sensorTandem Diabetes Care, Inc. K160056t:slim Insulin Delivery SystemTandem Diabetes Care, Inc. K160482t:slim Insulin Delivery System, t:flex Insulin Delivery System, Tandem Device UpdaterTandem Diabetes Care, Inc. K162080t:slim Insulin Delivery System, t:flex Insulin Delivery System, Tandem Device UpdaterTandem Diabetes Care, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑